Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s

Epilepsy and Behavior

Volumn 70, Issue , 2017, Pages 298-301

  Friedman, Daniel ^a   Sirven, Joseph I ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cannabinoids; Cannabis; Epilepsy; History; Seizure

Indexed keywords

CANNABIS; CANNABIDIOL; CANNABINOID; DRONABINOL; MEDICAL CANNABIS; NABIXIMOLS;

ANTIQUITY; CHINA; EPILEPSY; EUROPE; HISTORY OF MEDICINE; HUMAN; NONHUMAN; NORTH AMERICA; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; DRUG COMBINATION; HISTORY;

CANNABIDIOL; CANNABINOIDS; CANNABIS; DRONABINOL; DRUG COMBINATIONS; EPILEPSY; HISTORY, ANCIENT; HUMANS; MEDICAL MARIJUANA;

EID: 85009813123     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2016.11.033     Document Type: Review

References (33)

1. Schultes, R.E., Man and marihuana. Nat Hist, 82(7), 1973, 59.
2. Booth, M., Cannabis: a history. 1st Picador ed., 2005, Picador, New York [xiv, 429 p.p.].
3. Aldrich, M., Mathre, M., History of therapeutic cannabis. Mathre, M, (eds.) Cannabis in medical practice, 1997, Jefferson, NC: McFarland & Co, Publishers, 35–55.
4. Russo, E.B., History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers 4:8 (2007), 1614–1648.
5. Russo, E.B., The pharmacologic history of cannabis. Pertwee, R.G., (eds.) Handbook of cannabis, 2014, Oxford University Press, Oxford, UK, 23–43.
6. Lozano, I., The therapeutic use of Cannabis sativa L. in Arabic medicine. J Cannabis Ther 1:1 (2001), 63–70.
7. O'Shaughnessy, W.B., On the preparations of the Indian hemp, or gunjah (Cannabis indica). Transactions of the medical and physical society of Bengal, 1840, 71–102.
8. O'Shaughnessy, W.B., On the preparations of the Indian hemp, or gunjah: Cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Prov Med J Retrosp Med Sci, 5(123), 1843, 363.
9. Gowers, W.R., A manual of diseases of the nervous system. 1898, P. Blakiston, Son & Company.
10. Gowers, W., Epilepsy and other chronic convulsive disorders. 1881, Churchill, London.
11. Reynolds, J.R., Therapeutical uses and toxic effects of Cannabis indica. Lancet 1 (1868), 637–638.
12. Kalant, H., Medicinal use of cannabis: history and current status. Pain Res Manag 6:2 (2001), 80–91.
13. Pain, S., A potted history. Nature 525:7570 (2015), S10–S11.
14. Davis, J.P., Ramsey, H.H., Antiepileptic action of marijuana-active substances. Fed Proc 8 (1949), 284–285.
15. Mechoulam, R., Shvo, Y., Hashish, I., The structure of cannabidiol. Tetrahedron 19:12 (1963), 2073–2078.
16. Gaoni, Y., Mechoulam, R., Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:8 (1964), 1646–1647.
17. Keeler, M.H., Reifler, C.B., Grand mal convulsions subsequent to marijuana use. Case report. Dis Nerv Syst 28:7 Pt 1 (1967), 474–475.
18. Consroe, P.F., Wood, G.C., Buchsbaum, H., Anticonvulsant nature of marihuana smoking. JAMA 234:3 (1975), 306–307.
19. Feeney, D.M., Letter: marihuana use among epileptics. JAMA, 235(11), 1976, 1105.
20. Gordon, E., Devinsky, O., Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 42:10 (2001), 1266–1272.
21. Hamerle, M., Ghaeni, L., Kowski, A., Weissinger, F., Holtkamp, M., Cannabis and other illicit drug use in epilepsy patients. Eur J Neurol 21:1 (2014), 167–170.
22. Ng, S., Brust, J.C., Hauser, W.A., Susser, M., Illicit drug use and the risk of new-onset seizures. Am J Epidemiol 132:1 (1990), 47–57.
23. Hill, A.J., Hill, T.D.M., Whalley, B.J., The development of cannabinoid based therapies for epilepsy. Onaivi, E.S., Darmani, N.A., Wagner, E., (eds.) Endocannabinoids: molecular, pharmacological, behavioral and clinical features: Bentham Science, 2013, 164–204.
24. Perez-Reyes, M., Wingfield, M., Letter: cannabidiol and electroencephalographic epileptic activity. JAMA, 230(12), 1974, 1635.
25. Mechoulam, R., Carlini, E.A., Toward drugs derived from cannabis. Naturwissenschaften 65:4 (1978), 174–179.
26. Cunha, J.M., Carlini, E., Pereira, A.E., Ramos, O.L., Pimentel, C., Gagliardi, R., et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21:3 (1980), 175–185.
27. Ames, F.R., Cridland, S., Anticonvulsant effect of cannabidiol. S Afr Med J, 69(1), 1986, 14.
28. Trembly, B., Sherman, M., Double-blind clinical study of cannabidiol as a secondary anticonvulsant. Marijuana '90 International Conference on Cannabis and Cannabinoids Kolympari, Crete, July 8–11, 1990.
29. Gloss, D., Vickrey, B., Cannabinoids for epilepsy. Cochrane Database Syst Rev, 3, 2014, CD009270.
30. Devane, W.A., Dysarz, F.A. 3rd, Johnson, M.R., Melvin, L.S., Howlett, A.C., Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:5 (1988), 605–613.
31. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:5090 (1992), 1946–1949.
32. Feeney, D.M., Marihuana and epilepsy: paradoxical anticonvulsant and convulsant effects. Adv Biosci 22-23 (1978), 643–657.
33. Rosenberg, E.C., Tsien, R.W., Whalley, B.J., Devinsky, O., Cannabinoids and epilepsy. Neurotherapeutics 12:4 (2015), 747–768.